Back to search
FDAFDA · Food and drugs·Recall number D-0107-2017

Dream Body 450 mg 30 capsules in a plastic screw on top bottle

Published October 26, 2016 · Recall initiated: July 1, 2016

Summary

FDA records drug Class II recall D-0107-2017, published October 26, 2016 and initiated July 1, 2016. Recalling firm: Dream Body Weight Loss; Status: Terminated; Reported quantity: Unknown; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: Undeclared sibutramine.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dream Body Weight Loss
Distributor
United States
Lot
All lots.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dream Body 450 mg 30 capsules in a plastic screw on top bottle recalled?

Yes. FDA published recall D-0107-2017 on October 26, 2016. Reported hazard: Marketed without an approved NDA/ANDA: Undeclared sibutramine.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release